Zepbound 00002-6052
Generic: Tirzepatide
Product NDC
00002-6052- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 7, 2026
- Listing Expires
- December 31, 2027
- Application
- NDA217806
Need to source Zepbound? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tirzepatide | 4.17 mg/mL |
Drug Class
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]G-Protein-linked Receptor Interactions [MoA]
Packaging Options(1)
1 VIAL, MULTI-DOSE in 1 CARTON (0002-6052-11) / 2.4 mL in 1 VIAL, MULTI-DOSE (0002-6052-01)